Cre8 Biomatrix Xience valuePatients (n ) 14 11 12 Gender M/F, n (%) 11/3 (78.6/21.4) 7/4 (63.6/36.4) 10/2 (83.3/16.7) 0.519 Italian, n (%) 14 (100) 11 (100) 11 (91.7) 0.343 Age (years), mean ± SD 66.6 ± 10.0 67.1 ± 11.1 57.9 ± 12.2 0.087 BMI (Kg/m2 ), mean ± SD 26.9 ± 2.9 24.9 ± 1.6 28.2 3.0 0.036 Hypertension, n (%) 12 (85.7) 10 (90.9) 11 (91.7) 0.867 Diabetes, n (%) 4 (28.6) 3 (27.3) 3 (25) 0.979 Dyslipidemia, n (%) 11 (78.6) 9(81.8) 9 (75) 0.924 Ever smoker, n (%) 11 (78.6) 5 (45.5) 7 (58.3) 0.225 Familial history of CAD, n (%) 4 (28.6) 5 (45.5) 2 (16.7) 0.318 Previous CAD, n (%) 4 (28.6) 1 (9.1) 1 (8.3) 0.282 Previous PCI, n (%) 2 (14.3) 0 (0.0) 0 (0.0) 0.176 Previous CABG, n (%) 0 (0.0) 0 (0.0) 0 (0.0) — Previous TIA/stroke, n (%) 1 (7.1) 0 (0.0) 0 (0.0) 0.430 Chronic kidney disease, n (%) 1 (7.1) 0 (0.0) 0 (0.0) 0.430 COPD, n (%) 1 (7.1) 2 (18.2) 0 (0.0) 0.276 Sinus rhythm, n (%) 11 (100.0) 9 (81.8) 11 (91.7) 0.255 Atrial fibrillation, n (%) 0 (0.0) 1 (9.1) 0 (0.0) 0.297 Pacemaker, n (%) 0 (0.0) 1 (9.1) 1 (8.3) 0.524 LVEF, mean ± SD (%) 57 ± 6.4 59 ± 7.3 53 ± 8.9 0.164 Heart failure, n (%) 0 (0.0) 1 (9.1) 1 (8.3) 0.524 NYHA class 0.598 I°, n (%) 13 (92.9) 9 (81.8) 10 (83.3) II°, n (%) 0 (0.0) 0 (0.0) 1 (8.3) III°, n (%) 1 (7.1) 1 (9.1) 1 (8.3) IV°, n (%) 0 (0.0) 1 (9.1) 0 (0.0) Stable angina, n (%) 2 (14.3) 3 (27.3) 3 (25.0) 0.693 Unstable angina, n (%) 6 (42.9) 5 (45.5) 2 (16.7) 0.262 Silent ischemia, n (%) 1 (7.1) 0 (0.0) 2 (16.7) 0.338 NSTEMI, n (%) 3 (21.4) 3 (27.3) 3 (25.0) 0.942 STEMI, other vessels, n (%) 3 (21.4) 0 (0.0) 2 (16.7) 0.276 Target lesion coronary artery Left anterior descending 12 (85.7) 9 (81.8) 11 (91.7) 0.784 Left circumflex 7 (50.0) 4 (36.4) 7 (58.3) 0.570 Right 8 (57.1) 6 (54.5) 7 (58.3) 0.983 Left main 0 (0.0) 1 (9.1) 0 (0.0) 0.297
BMI: body mass index, CAD: coronary artery disease, PCI: percutaneous coronary intervention, CABG: coronary artery by-pass graft, TIA: transient ischemic attack, COPD: chronic obstructive pulmonary disease, LVEF: left ventricle ejection fraction.